Siren Biotechnology
San Francisco, CA
Siren Biotechnology blends two revolutionary therapeutic technologies into one for a novel approach to treating cancer.AAV gene therapy and cytokine immunotherapy are two revolutionary treatment approaches that Siren Biotechnology has combined into a single, redesigned modality. This approach overcomes significant obstacles and entirely transforms how tumor cells are eliminated and anti-tumor immunity is stimulated.
sirenbiotechnology.comCompany Details
Founded
- 2020
Employees
- Between 2 - 10 employees
Raised
- $23,611,194
Headquarters Location
- San Francisco, CA
Public
- No
Acquired
- No
Founders
- Nicole Paulk
Company Collections
These are collections Siren Biotechnology is a part of. Click on the collection name to view similar companies.